In a phase 3 trial, once-daily oral orforglipron induced significant, dose-dependent weight loss over 72 weeks in adults with ...

The two observational studies have limitations, including use of older GLP-1s, but still point to the strengths of bariatric ...

The popularity of glucagon-like peptide-1 (GLP-1) agonists like Ozempic, Wegovy and Mounjaro has exploded in recent years.

Pharmaceutical companies are racing to develop a GLP-1 weight-loss drug in pill form. Novo Nordisk says its oral semaglutide pill led to "significant weight loss" in a trial.

Obesity is linked to accelerated aging and early death and is typically defined by body mass index, a measure of weight and ...

A new type of weight loss jab can help maintain weight reductions by tackling the underlying causes of obesity, scientists ...

“Currently, less than 2% of individuals with obesity in the U.S. receive obesity medication and Wegovy in a pill may also ...

GLP-1 therapies not only aid weight loss but also reduce intrusive food thoughts and shift taste perception, which may ...

Makers of GLP-1 drugs, including Novo Nordisk, Eli Lilly and others, are close to releasing daily pills to help shed pounds ...

Wegovy has been a hugely popular treatment since the Food and Drug Administration (FDA) approved it for weight loss in ...

An IQVIA report published earlier this year found that 43% of anti-obesity assets currently in development are orally administered. By 2030, Goldman Sachs predicts this will translate to the pills’ ...

It's a trending topic: weight loss medication. But which one might be right for you? 7 News sat down with doctors from Bon ...